Valuation: Certara, Inc.

Capitalization 112.35Cr 97Cr 87Cr 84Cr 153Cr 10TCr 160.12Cr 1.03TCr 414.14Cr 4.95TCr 421.67Cr 412.68Cr 18TCr P/E ratio 2026 *
504x
P/E ratio 2027 * 188x
Enterprise value 112.59Cr 97Cr 88Cr 84Cr 153.33Cr 10TCr 160.46Cr 1.04TCr 415.02Cr 4.96TCr 422.56Cr 413.55Cr 18TCr EV / Sales 2026 *
2.63x
EV / Sales 2027 * 2.27x
Free-Float
74.41%
Yield 2026 *
-
Yield 2027 * -
1 day-1.26%
1 week-0.28%
Current month-0.28%
1 month-2.35%
3 months-23.43%
6 months-32.89%
Current year-19.86%
1 week 6.8
Extreme 6.8
7.52
1 month 6.04
Extreme 6.04
7.52
Current year 6.04
Extreme 6.04
10.2
1 year 6.04
Extreme 6.04
15.38
3 years 6.04
Extreme 6.04
24.96
5 years 6.04
Extreme 6.04
45.48
10 years 6.04
Extreme 6.04
45.48
Manager TitleAgeSince
Chief Executive Officer 53 01/01/2026
Director of Finance/CFO 53 01/04/2023
President 62 01/08/2023
Director TitleAgeSince
Chairman 72 01/12/2021
Director/Board Member 68 01/01/2013
Director/Board Member 59 01/08/2017
Change 5d. change 1-year change 3-years change Capi.($)
-1.26%-0.28%-39.24%-67.10% 112.35Cr
-0.42%+4.13%+3.04%+59.21% 3,03700Cr
+2.94%+14.56%+95.33%+1,798.07% 38TCr
-1.11%+5.65%-1.87%+18.61% 8.38TCr
-0.97%-1.48%+22.12%+50.43% 8.2TCr
-1.12%-1.96%+49.02%+1,165.90% 7.06TCr
-3.71%-15.19%-33.90%+39.98% 5.45TCr
-3.86%-7.47%+8.47%+56.59% 4.5TCr
-0.48%+0.01%+1.75%+82.78% 3.92TCr
+0.46%+1.00%-53.66%-49.60% 2.84TCr
Average -1.18%+0.18%+5.10%+315.49% 38.17TCr
Weighted average by Cap. -0.69%+2.95%+12.37%+248.91%

Financials

2026 *2027 *
Net sales 43Cr 37Cr 33Cr 32Cr 58Cr 3.94TCr 61Cr 394.64Cr 158.1Cr 1.89TCr 160.97Cr 157.54Cr 6.76TCr 45Cr 39Cr 35Cr 34Cr 62Cr 4.16TCr 64Cr 416Cr 166.66Cr 1.99TCr 169.69Cr 166.07Cr 7.13TCr
Net income -2L -2L -2L -2L -3L -2.16Cr -3L -21.67L -9L -1.04Cr -9L -9L -3.71Cr 29.82L 25.71L 23.21L 22.27L 40.61L 27Cr 42.5L 2.74Cr 1.1Cr 13Cr 1.12Cr 1.1Cr 47Cr
Net Debt 23.75L 20.48L 18.48L 17.74L 32.34L 22Cr 33.85L 2.19Cr 87.54L 10Cr 89.13L 87.23L 37Cr -9.72Cr -8.38Cr -7.56Cr -7.26Cr -13Cr -893.22Cr -14Cr -89Cr -36Cr -428.35Cr -36Cr -36Cr -1.53TCr
Logo Certara, Inc.
Certara, Inc. is engaged in model-informed drug development. The Company accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to efficiently carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services are underpinned by technologies such as regulatory submissions software, natural language processing and Bayesian analytics. It also develops scientific informatics software products used by the life sciences industry for in-silico research. It develops advanced modeling and biosimulation solutions used to predict the pharmacokinetic and pharmacodynamic properties. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 66 countries.
Employees
1,546
Date Price Change Volume
06/26/06 7.060 $ -1.26% 24,41,234
05/26/05 7.150 $ -2.72% 38,76,773
04/26/04 7.350 $ +1.52% 47,88,145
03/26/03 7.240 $ +2.70% 36,06,193
02/26/02 7.050 $ -0.42% 40,55,052
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
7.060USD
Average target price
9.604USD
Spread / Average Target
+36.04%

Quarterly revenue - Rate of surprise